rs1051730 risk_factor_for CPD
Evidence from:
primary |
all sources
Evidence (1 sources)
Nicotinic acetylcholine receptor variation and response to smoking cessation therapies.
(2013)
PMID:23249876
cited
rs1051730 is significantly and positively associated with CPD (p<0.001).
confidence: 0.95